Literature DB >> 17804694

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

Abderrahim Naji1, Solene Le Rond, Antoine Durrbach, Irene Krawice-Radanne, Caroline Creput, Marina Daouya, Julien Caumartin, Joel LeMaoult, Edgardo D Carosella, Nathalie Rouas-Freiss.   

Abstract

HLA-G is a tolerogenic molecule whose detection in sera and within allografted tissues is associated with better graft acceptance. HLA-G mediates T-cell differentiation into suppressor cells, which are thought to promote tolerance. Here, we investigated such T cells phenotypically and functionally and assessed their clinical relevance in the peripheral blood of patients who have undergone transplantation. Our results demonstrate that HLA-G expressed by antigen-presenting cells or present as soluble protein down-regulates the expression of CD4 and CD8 on allostimulated T cells at both transcriptional and posttranslational levels. These CD3(+)CD4(low) and CD3(+)CD8(low) T-cell subsets are characterized by an increased proportion of cells expressing CD45RA and HLA-DR, and a decreased number of cells expressing CD62L. In addition, these HLA-G-induced CD3(+)CD4(low) and CD3(+)CD8(low) subpopulations are Foxp3-negative suppressor T cells whose function involves IL-10. Biologic relevance came from analysis of patients who underwent transplantation, with high HLA-G plasma concentrations associated with better graft survival. Peripheral blood from these patients contains increased levels of IL-10 concomitantly to an enhanced representation of CD3(+)CD4(low) and CD3(+)CD8(low) T cells compared with HLA-G-negative patients who underwent transplantation and healthy individuals. These data define novel immunosuppressive subpopulations of peripheral blood T cells induced by HLA-G with potent implications in peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804694     DOI: 10.1182/blood-2007-04-083139

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

3.  Elimination of CD4lowHLA-G+ T cells overcomes castration-resistance in prostate cancer therapy.

Authors:  Chao Wang; Jiahuan Chen; Qianfei Zhang; Wang Li; Shengbo Zhang; Yanjie Xu; Fang Wang; Bing Zhang; Yan Zhang; Wei-Qiang Gao
Journal:  Cell Res       Date:  2018-10-08       Impact factor: 25.617

4.  Interaction among smoking status, single nucleotide polymorphisms and markers of systemic inflammation in healthy individuals.

Authors:  Thitiya Luetragoon; Lars E Rutqvist; Orathai Tangvarasittichai; Bengt-Åke Andersson; Sture Löfgren; Kanchana Usuwanthim; Nongnit L Lewin
Journal:  Immunology       Date:  2018-01-02       Impact factor: 7.397

5.  Levels of soluble human leukocyte antigen-G are increased in asthmatic airways.

Authors:  S R White; D A Loisel; J F McConville; R Stern; Y Tu; B A Marroquin; I Noth; C Ober
Journal:  Eur Respir J       Date:  2010-04       Impact factor: 16.671

6.  Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.

Authors:  Yuki Okushi; Kazuaki Okino; Kiyotaka Mukai; Yuki Matsui; Norifumi Hayashi; Keiji Fujimoto; Hiroki Adachi; Hideki Yamaya; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2017-03-31       Impact factor: 2.801

Review 7.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

8.  Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Authors:  Nathalie Rouas-Freiss; Joel LeMaoult; Jérôme Verine; Diana Tronik-Le Roux; Stéphane Culine; Christophe Hennequin; François Desgrandchamps; Edgardo D Carosella
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

9.  Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites.

Authors:  Ioanna Lazana; Anastasia Zoudiari; Dimitra Kokkinou; Maria Themeli; Maria Liga; Helen Papadaki; Dionysios Papachristou; Alexandros Spyridonidis
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

10.  Role and expression of non-classical human leukocyte antigen-G in renal transplanted allografts.

Authors:  Sho Kumano; Yuki Okushi; Keiji Fujimoto; Hiroki Adachi; Kengo Furuichi; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2021-01-04       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.